Dominic Piscitelli
Vermogen: 575 851 $ op 31-05-2026
Vermogen: 575 851 $ op 31-05-2026
Dominic Piscitelli is currently an Independent Director at Celyad Oncology SA since 2020, an Independent Director at Alterome Therapeutics, Inc. since 2024, and Chief Financial Officer at Oric Pharmaceuticals, Inc. since 2019.
Former roles include Chief Financial Officer at AnaptysBio, Inc. from 2017 to 2019, VP-Finance, Strategy & Investor Relations at Medivation LLC (California) from 2012 to 2017, Director-Collaborations & Operations Finance at Astellas Pharmaceuticals SA from 2011 to 2012, and Vice President-Treasury & Management Finance at OSI Pharmaceuticals, Inc. from 2009 to 2011.
Education includes undergraduate and MBAistration degrees from Hofstra University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 68.148 ( 0,07% ) | 575 851 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 01-09-2019 |
| CELYAD ONCOLOGY SA | Directeur/Bestuurslid | 06-05-2020 |
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Directeur/Bestuurslid | 01-04-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ANAPTYSBIO, INC. | Financieel Directeur/CFO | 16-08-2019 |
| MEDIVATION INC | Financieel Directeur/CFO | 01-01-2017 |
Astellas Pharmaceuticals SA | Corporate Officer/Principal | 01-09-2012 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Hofstra University
Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Celyad Oncology SA
Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Astellas Pharmaceuticals SA | |
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau